- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06616610
Single-Button Mobility Platform's Effect on Reaction Time and Keystroke Accuracy in Children with Cerebral Palsy
Single-Button Mobility Platform's Effect on Reaction Time and Keystroke Accuracy in Children with Cerebral Palsy: a Pilot Study
The goal of this clinical trial is to determine whether the use of a mobility platform can improve response time in children with cerebral palsy.
The primary question it seeks to answer is: Can the use of a mobility platform enhance cognitive development in children with severe disabilities?
Children are randomly assigned to two equal-sized groups: the control group, where participants will continue with their standard therapy, and the intervention group, where participants will use the mobility platform. Researchers will compare outcomes between the two groups.
Participants in the control group will engage in a traditional cause-and-effect therapy, using a video that frequently pauses, requiring them to press an adapted button to continue watching. Participants in the intervention group will use the mobility platform during their sessions. Movement begins when the participant presses the adapted button, and the platform advances, adjusting its direction using sensors to detect obstacles. Once the preset time limit is reached, the platform stops, and the child must press the button again to resume movement. This stop-start process mirrors the cause-and-effect training in the control group.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The experimental timeline includes eight weekly sessions, each lasting 30 minutes. Initially, therapists will receive an explanation on how to use the platform and the accompanying configuration application. They will familiarize themselves with it a couple of weeks before the experiment begins. During the sessions, children in the experimental group will use the platform, while those in the control group will continue receiving their traditional therapy.
Researchers will pre-adjust the children's interactions to match the platform variables, allowing for meaningful comparisons. Therapists will assess changes in the children's mood or emotional state during each session. To do this, they will calculate the differences between the SAM (Self-Assessment Manikin) tests conducted at the beginning and end of each session. A positive difference in valence indicates an improvement in the participant's happiness or positive emotions during the session. Similarly, positive changes in arousal reflect increased calmness or reduced excitation. A seven-item Likert scale will be used for measurement. For instance, if there is a positive change of seven points in valence during a session, the participant moves from a very sad state to a very happy one.
To minimize bias in conducting the experiment and evaluating SAM tests, therapists will be randomly assigned to either the control or intervention groups for each session, while ensuring an equal number of sessions conducted by each therapist. As a result, each therapist will conduct four sessions with the experimental group and four with the control group, with random session assignments.
The dependent variables include reaction time (RT) and the number of incorrect selections (NIS). The mean and standard deviation of these dependent variables allow for the following statistical analyses: Kruskal-Wallis Test: This will be used to compare the dependent variables across groups. SAM Test: It will score the statistically significant differences between the experimental and control groups, with the level of significance set at 5% (p = 0.05). Pearson Regression Analysis: This will identify trends in the dependent variables over time.
The registration procedure is as follows: Variables are collected, transmitted, and stored in a database on a cellphone for later analysis. To achieve this, the investigators used an Open Source Frontend SDK , which enables the deployment of hybrid mobile applications based on web development tools such as HTML, CSS, and JavaScript. The apps run in a browser shell. Several Capacitor plugins were used to manage the database and Bluetooth connectivity, which are essential for data storage and communication. The application interface includes buttons for therapists to enable/disable Bluetooth connections, start/stop recording, and a panic button to halt the platform and abort the experiment. Additionally, users can select their username and group name. Control group therapy involves the use of educational resources that require children to press a button repeatedly. For this group, the investigators chose fairy tale or cartoon videos from YouTube. The specific videos will be tailored to the user's preferences. These videos pause intermittently and require the child to perform an action to resume playback. A microcontroller is used to record time intervals and host an application that detects the child's keystrokes. This data is transmitted via Bluetooth to the same mobile application used for the mobility platform, ensuring synchronization between the experimental and control groups.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Félix Biscarri, PhD
- Phone Number: +34 954552836
- Email: fbiscarri@us.es
Study Contact Backup
- Name: Alberto Molina Cantero, PhD
- Phone Number: +34 954552787
- Email: almolina@us.es
Study Locations
-
-
Andalucia
-
Seville, Andalucia, Spain, 41010
- Recruiting
- University of Seville
-
Contact:
- Félix Biscarri, PhD
- Phone Number: +34 954552826
- Email: fbiscarri@us.es
-
Contact:
- Alberto Molina, PhD
- Phone Number: +34 954552787
- Email: almolina@us.es
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosed with cerebral palsy
- Classified as GMFCS level IV or higher, indicating an inability to walk or operate a powered wheelchair.
- Under 12 years old.
- Must be affiliated to a center whose facilities guarantee a proper navigation experience
Exclusion Criteria:
- Inability to act on an actuator (Start button)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: The Experimental Arm
Participants included in arms are children with the following inclusion criteria:
The participants will be randomly assigned to two equal-sized arms: the control arm, in which participants will continue with the traditional therapy, and the experimental arm, where the children will use the platform. The experimental arm receives an intervention (procedure) that is a focus of the study. It aims to analyze the impact of a single-button-operated mobility platform on reaction times and keypress patterns in children with severe disabilities. |
The experimental arm receives the Intervention with Mobility Platform that is a focus of the study.
It aims to analyze the impact of a single-button-operated mobility platform on reaction times and keypress patterns in children with severe disabilities.
|
|
Active Comparator: The Control Arm
Participants included in arms are children with the following inclusion criteria: - Diagnosed with cerebral palsy - Classified as GMFCS level IV or higher, indicating an inability to walk or operate a powered wheelchair.
- Under 12 years old.
- Must be affiliated to a center whose facilities guarantee a proper navigation experience The participants will be randomly assigned to two equal-sized arms: the control arm, in which participants will continue with the traditional therapy, and the experimental arm, where the children will use the platform.
The control arm participants continue with their regular therapy.
Regular cause-effect therapies use an animated cartoon video that frequently pauses so that the children have to press an adapted button to continue watching it.
|
The traditional cause-effect therapies use an animated cartoon video that frequently pauses so that the children have to press an adapted button to continue watching it.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reaction time (RT)
Time Frame: From enrollment to the end of treatment at 8 weeks
|
In the intervention group, RT measures the time elapsed between the platform stopping and the user pressing the button to initiate a new navigation period. In the control group, RT measures the time elapsed between the video pausing and the user pressing the button to continue watching it |
From enrollment to the end of treatment at 8 weeks
|
|
Number of incorrect selections (NIS)
Time Frame: From enrollment to the end of treatment at 8 weeks
|
NIS represents the number of additional button presses recorded while the Platform is in motion and serves validation purposes.
A high value of this variable, consistently maintained over time, suggests that the user is not performing the cause-effect experiment effectively.
|
From enrollment to the end of treatment at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Self-Assessment Manikin (SAM) test
Time Frame: From enrollment to the end of treatment at 8 weeks
|
The Self-Assessment Manikin (SAM) test is used to assess the emotional changes in children during the experiment. It comprises a 7-level Likert scale (the scale ranges from 1 to 7) associated with a set of faces displaying various degrees of valence and arousal. Valence reflects how pleasant or unpleasant an emotion. A score of 1 represents the most unpleasant emotion, while a score of 7 represents the most pleasant emotion. Arousal refers to the level of physiological and psychological activation or intensity of an emotional experience. A score of 1 indicates low arousal (low physiological and psychological activation), and a score of 7 indicates high arousal (high activation). Thus, higher scores mean more positive valence (pleasant emotion) and higher arousal (greater intensity). |
From enrollment to the end of treatment at 8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alberto Molina Cantero, PhD, University of Seville, Seville, Andalucia, Spain
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEIBA_0669-N-22
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Study Data/Documents
-
Individual Participant Data Set
Information comments: The idUS repository is part of the digital infrastructures for open science guaranteed by the National Strategy for Open Science (ENCA). It allows authors from the University of Seville (US) to deposit their publications in open access and manage their research data according to FAIR principles (Findable, Accessible, Interoperable, and Reusable).
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebral Palsy Infantile
-
University of California, San FranciscoNot yet recruitingCerebral Palsy | Cerebral Palsy (CP) | Infant | Cerebral Palsy InfantileUnited States
-
University of Castilla-La ManchaNot yet recruitingCerebral Palsy Infantile
-
Centre Médico-Chirurgical de Réadaptation des Massues...CompletedCerebral Palsy, Dyskinetic | Cerebral Palsy, Spastic | Infantile Hemiplegic Cerebral PalsyFrance
-
HugelCompletedOther Infantile Cerebral PalsyKorea, Republic of
-
Centre Hospitalier Universitaire de NīmesRecruitingCerebral Palsy InfantileFrance
-
IRCCS Fondazione Stella MarisUniversity of Pisa; Azienda Ospedaliero, Universitaria PisanaNot yet recruiting
-
Kelly TannerCompletedCerebral Palsy | Cerebral Palsy, Diplegic, InfantileUnited States
-
Chaitanya Hospital, PuneUnknownAtaxic Infantile Cerebral PalsyIndia
-
G. d'Annunzio UniversityFondazione Centri di Riabilitazione Padre Pio Onlus - Gli Angeli di Padre...RecruitingCerebral Palsy Infantile | Robotic Assisted Gait TrainingItaly
-
University Hospital, BrestRecruiting
Clinical Trials on Intervention with the Mobility Platform
-
Jiangsu Province Nanjing Brain HospitalRecruiting
-
Juan Victor LorenteEdwards LifesciencesCompleted
-
Centre Hospitalier Universitaire DijonCompleted
-
McGill UniversityRichard and Edith Strauss Foundation of CanadaCompletedSeniors With Mobility LimitationsCanada
-
Taizhou Hospital of Zhejiang Province affiliated...Completed
-
University of Alabama at BirminghamNational Eye Institute (NEI); New Jersey Institute of TechnologyCompletedLow Vision, Both EyesUnited States
-
Stryker Trauma GmbHCompletedFemur Head Necrosis | Primary Osteoarthritis | Congenital Dislocations | Femur Neck Fracture | Post-traumatic Osteoarthritis of Hip Nos
-
Centre for Interdisciplinary Research in Rehabilitation...Not yet recruitingCardiovascular Diseases | Stroke | Traumatic Brain Injuries | Aquired Brain InjuryCanada
-
Jonathan PearlmanEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingDisability Physical | Wheelchair | Obesity; OverweightUnited States
-
Auris Health, Inc.Terminated